Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calprotectin I in Serum as a Diagnostic Marker of Pneumonia in Patients Hospitalised With Acute COPD Exacerbation

NCT03474484 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT03474484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03474484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calprotectin I in Serum as a Diagnostic Marker of Pneumonia in Patients Hospitalised With Acute COPD Exacerbation
Lead sponsor
St. Olavs Hospital
Phase
Observational
Overall status
Completed
Start date
April 3, 2018
Completion date
September 14, 2018
Enrollment
113 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease, chronic obstructive